Cover Image
Market Research Report
Product code 
968723

Cervical Dysplasia Market, By Product Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published: | Coherent Market Insights | 145 Pages | Delivery time: 2-3 business days

Price

Back to Top
Cervical Dysplasia Market, By Product Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Published: September 18, 2020
Coherent Market Insights
Content info: 145 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Title:
Cervical Dysplasia Market, By Product Type (Diagnostic Test, Diagnostic Devices), By End User (Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic institutes, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

  • Cervical dysplasia is a precancerous condition characterized by abnormal growth of endocervical canal cells. Cervical dysplasia is also called as cervical intraepithelial neoplasia. Cervical dysplasia can be of two types based on the type of cells it affect - squamous intraepithelial lesion and glandular cell lesions. The cervical dysplasia diagnostic market is expected to witness significant growth over the forecast period, owing to increasing prevalence of disease and increasing awareness regarding utilization of detection test through government screening programmes for regular screening.

Key features of the study:

  • This report provides in-depth analysis of the Global Cervical Dysplasia market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Cervical Dysplasia market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, F. Hoffmann La-Roche Ltd., QIAGEN N.V., Becton, Dickinson and Company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., Abbott Laboratories, ASKA Pharmaceutical Co., Ltd., Asieris Pharmaceuticals, BetterLife Pharma Inc., and KinoPharma, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Cervical Dysplasia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cervical Dysplasia market

Detailed Segmentation:

  • Global Cervical Dysplasia Market, By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
  • Global Cervical Dysplasia Market, By End User:
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
  • Global Cervical Dysplasia Market, By Region:
  • North America
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • F. Hoffmann La-Roche Ltd. *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • OncoHealth Corporation
  • Quest Diagnostics, Inc.
  • Hologic, Inc.
  • Abbott Laboratories
  • ASKA Pharmaceutical Co., Ltd.
  • Asieris Pharmaceuticals
  • BetterLife Pharma Inc.
  • KinoPharma, Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Cervical Dysplasia Market, By Product Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Diagnostic Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Diagnostic Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Cervical Dysplasia Market, By End User, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Private Gynecologists' Offices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Research & Academic institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Cervical Dysplasia Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • F. Hoffmann La-Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • QIAGEN N.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • OncoHealth Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Quest Diagnostics, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hologic, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ASKA Pharmaceutical Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Asieris Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BetterLife Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • KinoPharma, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact